Evidence map›Paper›PMID 40289861›Full record

Observational studyAlzheimer's & dementia : the journal of the Alzheimer's Association2025

Microstructural assessment of the locus coeruleus-entorhinal cortex pathway and association with ATN markers in cognitive impairment.

Marco Aiello, Moira Marizzoni, Pasquale Borrelli, Carlo Cavaliere, Federica Ribaldi, Valentina Garibotto, Max Scheffler, Ileana O Jelescu, Jorge Jovicich, Marco Catani and 3 more

Abstract readObservational Study
In one paragraph

Observational study in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Locus coeruleus-entorhinal cortex tract integrity is linked to plasma tau and glial fibrillary acidic protein.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  6. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Marco AielloIRCCS SYNLAB SDN, Naples, Italy.
Moira MarizzoniBiological Psychiatry Unit, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy.
Pasquale BorrelliIRCCS SYNLAB SDN, Naples, Italy.
Carlo CavaliereIRCCS SYNLAB SDN, Naples, Italy.
Federica RibaldiLaboratory of Neuroimaging of Aging (LANVIE), University of Geneva, Geneva, Switzerland.
Valentina GaribottoLaboratory of Neuroimaging and Innovative Molecular Tracers (NIMTlab), Geneva University Neurocenter and Faculty of Medicine, University of Geneva, Geneva, Switzerland.
Max SchefflerDivision of Radiology, Geneva University Hospitals, Geneva, Switzerland.
Ileana O JelescuLausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.
Jorge JovicichCenter for Mind/Brain Sciences, University of Trento, Mattarello, Italy.
Marco CataniIRCCS SYNLAB SDN, Naples, Italy.
Marco SalvatoreIRCCS SYNLAB SDN, Naples, Italy.
Giovanni B FrisoniLaboratory of Neuroimaging of Aging (LANVIE), University of Geneva, Geneva, Switzerland.
Michela PievaniLaboratory of Alzheimer's Neuroimaging and Epidemiology, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy.

Funding

A.P.R.A.-Association Suisse pour la Recherche sur la Maladie d'AlzheimerFondation AETASFondation Child CareFondation Edmond J. SafraFondation MinkoffFondation SegréFondazione AgustaH2020 667375Innovative Medicines Initiative 115736Innovative Medicines Initiative 115952Italian Ministry of Health GR-2018-12366779Italian Ministry of Health RicercaCorrenteItalian Ministry of University and ResearchMcCall Macbain FoundationMNESYS PE0000006National Recovery and Resilience PlanNicole et René KellerPrivate Foundation of Geneva University HospitalsRace Against Dementia FoundationSchmidheiny foundationSNSF Eccellenza PCEFP2_194260Swiss National Science Foundation 320030_169876Swiss National Science Foundation 320030_182772Swiss National Science Foundation 320030_185028VELUX Foundation
6 · The paper itself

Abstract

introductionWhether Alzheimer's disease pathology involves white matter pathways connecting the locus coeruleus (LC) to the entorhinal cortex (EC) is unclear. In this cross-sectional observational study, we investigated the microstructural integrity of the LC-EC pathway in relation to amyloid, tau, and neurodegeneration (ATN) biomarkers along the cognitive spectrum from normal cognition to dementia.

methodsOne hundred twenty-four participants underwent clinical assessment, diffusion-weighted imaging, structural magnetic resonance imaging (N), amyloid (A), and tau (T) positron emission tomography. Diffusivity indices were assessed in the LC-EC tract using a probabilistic atlas, and linear models were used to assess associations with ATN markers and cognition.

resultsDifferences in LC-EC microstructural parameters were observed in participants with Braak stage > I versus Braak 0 (p < 0.020), N+ versus N- (p < 0.001), and cognitively impaired versus unimpaired (p < 0.019). LC-EC mean diffusivity was associated with Mini-Mental State Examination score even after accounting for ATN markers (p = 0.015). DISCUSSION: Our results suggest that LC-EC diffusivity provides complementary information over ATN biomarkers in explaining cognitive impairment. HIGHLIGHTS: Locus coeruleus-entorhinal cortex (LC-EC) tract microstructure is associated with tau and especially neurodegeneration markers. LC-EC tract microstructure is more sensitive to tau pathology and neurodegeneration than tracts commonly affected in Alzheimer's disease. LC-EC diffusivity measures provide complementary information over amyloid, tau, and neurodegeneration (ATN) biomarkers.

Indexed as

Cognitive DysfunctionEntorhinal CortexLocus CoeruleusNeural PathwaysAgedAlzheimer DiseaseAmyloid beta-PeptidesBiomarkersCross-Sectional StudiesFemaleHumansMagnetic Resonance ImagingMaleMiddle AgedPositron-Emission Tomographytau ProteinsAmyloid beta-PeptidesBiomarkerstau Proteinsamyloid/tau/neurodegenerationdementiadiffusion‐weighted imagingentorhinal cortexlocus coeruleusmagnetic resonance imaging

Identifiers

PMID40289861
PMCPMC12035542

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.